Proteomics-based investigations of animal models of disease

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 638-653

  Bousette, Nicolas ^a   Gramolini, Anthony O ^a,b   Kislinger, Thomas ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Animal models; Biomarkers; Post translational modifications; Protein interactions; Standard proteomes

Indexed keywords

ACETAZOLAMIDE; AMINOPEPTIDASE; BIOLOGICAL MARKER; CALMODULIN; CALPAIN 3; CARBONATE DEHYDRATASE I; COPPER ZINC SUPEROXIDE DISMUTASE; FLUORESCENT DYE; FRAGILE X MENTAL RETARDATION PROTEIN; HISTIDINE; IMATINIB; LEPTIN; LIPOCORTIN 1; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 1; OSTEOPONTIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROLACTIN; PROTEIN 14 3 3; PROTEIN A; PROTEOME; SOMATOMEDIN B; STREPTAVIDIN; TRASTUZUMAB;

ACUTE GLOMERULONEPHRITIS; AFRICAN TRYPANOSOMIASIS; AMYOTROPHIC LATERAL SCLEROSIS; BLINDNESS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ACTIVITY; DRUG TARGETING; ENZYME PHOSPHORYLATION; EXPERIMENTAL ANIMAL; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIVER FAILURE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEOMICS; RETINA MACULA EDEMA; REVIEW; TUMOR GROWTH; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALIA;

EID: 44649105713     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780043     Document Type: Review

References (174)

1. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
2. Klose, J., Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 1975, 26, 231-243.
3. Wu, S. L., Choudhary, G., Ramstrom, M., Bergquist, J. et al., Evaluation of shotgun sequencing for proteomic analysis of human plasma using HPLC coupled with either ion trap or Fourier transform mass spectrometry. J. Proteome Res. 2003, 2, 383-393.
4. Braun, R. J., Kinkl, N., Beer, M., Ueffing, M., Two-dimensional electrophoresis of membrane proteins. Anal. Bioanal. Chem. 2007, 389, 1033-1045.
5. Marouga, R., David, S., Hawkins, E., The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 2005, 382, 669-678.
6. Michel, H., Griffin, P. R., Shabanowitz, J., Hunt, D. F. et al., Tandem mass spectrometry identifies sites of three post-translational modifications of spinach light-harvesting chlorophyll protein II. Proteolytic cleavage, acetylation, and phosphorylation. J. Biol. Chem. 1991, 266, 17584-17591.
7. Washburn, M. P., Wolters, D., Yates, J. R.3rd, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
8. Baldwin, M. A., Analysis of glycosylphosphatidylinositol protein anchors: the prion protein. Methods Enzymol. 2005, 405, 172-187.
9. Liu, H., Sadygov, R. G., Yates, J. R.3rd, A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
10. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F. et al., Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246, 64-71.
11. Karas, M., Hillenkamp, F., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60, 2299-2301.
12. Ong, S. E., Mann, M., Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252-262.
13. Andersen, J. S., Mann, M. Organellar proteomics: turning inventories into insights. EMBO Rep. 2006, 7, 874-879.
14. Steen, H., Mann, M., The ABC's (and XYZ's) of peptide sequencing. Nat. Rev. Mol. Cell Biol. 2004, 5, 699-711.
15. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
16. Yates, J. R.3rd, Mass spectral analysis in proteomics. Annu. Rev. Biophys. Biomol. Struct. 2004, 33, 297-316.
17. Yates, J. R., 3rd, Gilchrist, A., Howell, K. E., Bergeron, J. J., Proteomics of organelles and large cellular structures. Nat. Rev. Mol. Cell Biol. 2005, 6, 702-714.
18. Mann, K. G., Brummel-Ziedins, K., Undas, A., Butenas, S., Does the genotype predict the phenotype? Evaluations of the hemostatic proteome. J. Thromb. Haemost. 2004, 2, 1727-1734.
19. Massignan, T., Casoni, F., Basso, M., Stefanazzi, P. et al., Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem. Biophys. Res. Commun. 2007, 353, 719-725.
20. Huang, C. M., Wang, C. C., Kawai, M., Barnes, S. et al., In vivo protein sampling using capillary ultrafiltration semi-permeable hollow fiber and protein identification via mass spectrometry-based proteomics. J. Chromatogr. A 2006, 1109, 144-151.
21. Ruddat, V. C., Whitman, S., Klein, R. D., Fischer, S. M. et al., Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma. Prostate 2005, 64, 128-138.
22. Oh, P., Li, Y., Yu, J., Durr, E. et al., Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004, 429, 629-635.
23. Chudley, A. E., Hagerman, R. J., Fragile X syndrome. J. Pediatr. 1987, 110, 821-831.
24. Zhang, Y. Q., Friedman, D. B., Wang, Z., Woodruff, E.3rd et al., Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol. Cell. Proteomics. 2005, 4, 278-290.
25. Hesslinger, C., Kremmer, E., Hultner, L., Ueffing, M. et al., Phosphorylation of GTP cyclohydrolase I and modulation of its activity in rodent mast cells. GTP cyclohydrolase I hyperphosphorylation is coupled to high affinity IgE receptor signaling and involves protein kinase C. J. Biol. Chem. 1998, 273, 21616-21622.
26. O'Donnell, W. T., Warren, S. T., A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 2002, 25, 315-338.
27. Nathan, D. M., Long-term complications of diabetes mellitus. N. Engl. J. Med. 1993, 328, 1676-1685.
28. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J. et al., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13, 181-188.
29. Richard, I., Broux, O., Allamand, V., Fougerousse, F. et al., Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81, 27-40.
30. Cohen, N., Kudryashova, E., Kramerova, I., Anderson, L. V. et al., Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice. Proteomics 2006, 6, 6075-6084.
31. Broadhead, R., Dawe, H. R., Farr, H., Griffiths, S. et al., Flagellar motility is required for the viability of the bloodstream trypanosome. Nature 2006, 440, 224-227.
32. Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C. et al., A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003, 21, 921-926.
33. Jeon, H. B., Choi, E. S., Yoon, J. H., Hwang, J. H. et al., A proteomics approach to identify the ubiquitinated proteins in mouse heart. Biochem. Biophys. Res. Commun. 2007, 357, 731-736.
34. Villen, J., Beausoleil, S. A., Gerber, S. A., Gygi, S. P., Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. USA 2007, 104, 1488-1493.
35. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B. et al., Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127, 635-648.
36. Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L. et al., Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 39, 453-462.
37. Poon, H. F., Farr, S. A., Banks, W. A., Pierce, W. M. et al., Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res. Mol. Brain Res. 2005, 138, 8-16.
38. Soreghan, B. A., Lu, B. W., Thomas, S. N., Duff, K. et al., Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alzheimer's disease. J. Alzheimers Dis. 2005, 8, 227-241.
39. Gingras, A. C., Gstaiger, M., Raught, B., Aebersald, R., Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol. 2007, 8, 645-654.
40. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M. et al., A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999, 17, 1030-1032.
41. Krogan, N. J., Cagney, G., Yu, H., Zhong, G. et al., Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006, 440, 637-643.
42. Mackintosh, C., Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 2004, 381, 329-342.
43. Angrand, P. O., Segura, I., Volkel, P., Ghidelli, S. et al., Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol. Cell. Proteomics 2006, 5, 2211-2227.
44. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
45. Mor, G., Visintin, I., Lai, Y., Zhao, H. et al., Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. USA 2005, 102, 7677-7682.
46. Lv, S., Wei, L., Wang, J. H., Wang, J. Y. et al., Identification of novel molecular candidates for acute liver failure in plasma of BALB/ c murine model. J. Proteome Res. 2007, 6, 2746-2752.
47. Bhat, V. B., Choi, M. H., Wishnok, J. S., Tannenbaum, S. R., Comparative plasma proteome analysis of lymphoma-bearing SJL mice. J. Proteome Res. 2005, 4, 1814-1825.
48. Jaiswal, M., LaRusso, N. F., Gores, G. J., Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G626-G634.
49. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
50. Braun, M. C., Li, L., Ke, B., Dubinsky, W. P. et al., Proteomic profiling of urinary protein excretion in the factor H-deficient mouse. Am. J. Nephrol. 2006, 26, 127-135.
51. Kislinger, T., Cox, B., Kannan, A., Chung, C. et al., Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125, 173-186.
52. Cutillas, P. R., Vanhaesebroeck, B., Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol. Cell. Proteomics 2007.
53. Foster, L. J., de Hoog, C. L., Zhang, Y., Zhang, Y. et al., A mammalian arganelle map by protein correlation profiling. Cell 2006, 125, 187-199.
54. Shi, R., Kumar, C., Zougman, A., Zhang, Y. et al., Analysis of the mouse liver proteome using advanced mass spectrometry. J. Proteome Res. 2007, 6, 2963-2972.
55. Gilchrist, A., Au, C. E., Hiding, J., Bell, A. W. et al., Quantitative proteomics analysis of the secretory pathway. Cell 2006, 127, 1265-1281.
56. Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M. et al., Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 2003, 115, 629-640.
57. Schirmer, E. C., Florens, L., Guan, T., Yates, J. R.3rd et al., Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 2003, 301, 1380-1382.
58. Andersen, J. S., Lam, Y. W., Leung, A. K., Ong, S. E. et al., Nucleolar proteome dynamics. Nature 2005, 433, 77-83.
59. Cox, B., Kislinger, T., Wigle, D. A., Kannan, A. et al., Integrated proteomic and transcriptomic profiling of mouse lung development and Nmyc target genes. Mol. Syst. Biol. 2007, 3, 109.
60. Van Hoof, D., Passier, R., Ward-Van Oostwaard, D., Pinkse, M. W. et al., A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 2006, 5, 1261-1273.
61. Hood, B. L., Zhou, M., Chan, K. C., Lucas, D. A. et al., Investigation of the mouse serum proteome. J. Proteome Res. 2005, 4, 1561-1568.
62. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
63. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V. et al., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006, 7, R80.
64. Koomen, J. M., Wilson, C. R., Guthrie, P., Androlewicz, M.J. et al., Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J. Proteome Res. 2006, 5, 177-182.
65. Lang, S. C., Elsasser, A., Scheler, C., Vetter, S. et al., Myocardial preconditioning and remote renal preconditioning-identifying a protective factor using proteomic methods? Basic Res. Cardiol. 2006, 101, 149-158.
66. Yan, L., Vatner, D. E., Kim, S. J., Ge, H. et al., Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. USA 2005, 102, 13807-13812.
67. Faber, M. J., Dalinghaus, M., Lankhuizen, I. M., Bezstarosti, K. et al., Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 2005, 5, 2519-2530.
68. Shen, X., Zheng, S., Thongboonkerd, V., Xu, M. et al., Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E896-E905.
69. Buscemi, N., Doherty-Kirby, A., Sussman, M. A., Lajoie, G. et al., Proteomic analysis of Rac1 transgenic mice displaying dilated cardiomyopathy reveals an increase in creatine kinase M-chain protein abundance. Mol. Cell Biochem. 2003, 251, 145-151.
70. Lohr, N. L., Warltier, D. C., Chilian, W. M., Weihrauch, D. Haptoglobin expression and activity during coronary collateralization. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H1389-H1395.
71. Cho, W. C., Yip, T. T., Chung, W. S., Lee, S. K. et al., Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDI-TOF MS. J. Ethnopharmacol 2006, 108, 272-279.
72. Morand, J. P., Macri, J., Adeli, K., Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J. Biol. Chem. 2005, 280, 17626-17633.
73. Satoh, M., Haruta-Satoh, E., Omori, A., Oh-Ishi, M. et al., Effect of thyroxine on abnormal pancreatic proteomes of the hypothyroid rdw rat. Proteomics 2005, 5, 1113-1124.
74. Matsumura, T., Suzuki, T., Kada, N., Aizawa, K. et al., Differential serum proteomic analysis in a model of metabolic disease. Biochem. Biophys. Res. Commun. 2006, 351, 965-971.
75. Edvardsson, U., Alexandersson, M., Brockenhuus von Lowenhielm, H., Nystrom, A. C. et al., A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis 1999, 20, 935-942.
76. Venkatraman, A., Landar, A., Davis, A. J., Ulasova, E. et al., Oxidative modification of hepatic mitochondria protein thiols: effect of chronic alcohol consumption. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 288, G521-G527.
77. Van Greevenbroek, M. M., Vermeulen, V. M., De Bruin, T. W., Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19. J. Lipid Res. 2004, 45, 1148-1154.
78. Douette, P., Navet, R., Gerkens, P., de Pauw, E. et al., Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4, 2024-2031.
79. Henkel, C., Roderfeld, M., Weiskirchen, R., Berres, M. L. et al., Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 2006, 6, 6538-6548.
80. Liu, E. H., Chen, M. F., Yeh, T. S., Ho, Y. P. et al., A useful model to audit liver resolution from cirrhosis in rats using functional proteomics. J. Surg. Res. 2007, 138, 214-223.
81. Svetlov, S. I., Xiang, Y., Oli, M. W., Foley, D. P. et al., Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/ degradomic approaches. Biomarkers 2006, 11, 355-369.
82. Amacher, D. E., Adler, R., Herath, A., Townsend, R. R., Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin. Chem. 2005, 51, 1796-1803.
83. Welch, K. D., Wen, B., Goodlett, D. R., Yi, E. C. et al., Proteomic identification of potential susceptibility factors in drug-induced liver disease. Chem. Res. Toxicol. 2005, 18, 924-933.
84. Simpson, D. M., Beynon, R. J., Robertson, D. H., Loughran, M. J. et al., Copper-associated liver disease: a proteomics study of copper challenge in a sheep model. Proteomics 2004, 4, 524-536.
85. Gerling, I. C., Singh, S., Lenchik, N. I., Marshall, D. R. et al., New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol. Cell. Proteomics 2006, 5, 293-305.
86. Mouquet, H., Drouot, L., Charlionnet, R., Arnoult, C. et al., Proteomic analysis of the autoantibody response following immunization with a single autoantigen. Proteomics 2006, 6, 4829-4837.
87. Fijak, M., Iosub, R., Schneider, E., Linder, M. et al., Identification of immunodominant autoantigens in rat autoimmune orchitis. J. Pathol. 2005, 207, 127-138.
88. Boots, A. M., Verhaert, P. D., te Poele, R. J., Evers, S. et al., Antigens up the nose: identification of putative biomarkers for nasal tolerance induction functional studies combined with proteomics. J. Proteome Res. 2004, 3, 1056-1062.
89. Qin, H. Y., Mukherjee, R., Lee-Chan, E., Ewen, C. et al., A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int. Immunol. 2006, 18, 1001-1015.
90. Baas, T., Baskin, C. R., Diamond, D. L., Garcia-Sastre, A. et al., Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 2006, 80, 10813-10828.
91. Booy, A. T., Haddow, J. D., Ohlund, L. B., Hardie, D. B. et al., Application of isotope coded affinity tag (ICAT) analysis for the identification of differentially expressed proteins following infection of atlantic salmon (Salmo salar) with infectious hematopoietic necrosis virus (IHNV) or Renibacterium salmoninarum (BKD). J. Proteome Res. 2005, 4, 325-334.
92. Chung, J. W., Speert, D. P., Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host. Microbiology 2007, 153, 206-214.
93. Klein, L. L., Freitag, B. C., Gibbs, R. S., Reddy, A. P. et al., Detection of intra-amniotic infection in a rabbit model by proteomics-based amniotic fluid analysis. Am. J. Obstet. Gynecol. 2005, 193, 1302-1306.
94. Li, Q. Z., Xie, C., Wu, T., Mackay, M. et al., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115, 3428-3439.
95. Havlasova, J., Hernychova, L., Brychta, M., Hubalek, M. et al., Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 2005, 5, 2090-2103.
96. Holly, M. K., Dear, J. W., Hu, X., Schechter, A. N. et al., Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int. 2006, 70, 496-506.
97. Rosca, M. G., Mustata, T. G., Kinter, M. T., Ozdemir, A. M. et al., Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal Physiol. 2005, 289, F420-F430.
98. Ngai, H. H., Sit, W. H., Jiang, P. P., Thongboonkerd, V. et al., Markedly increased urinary preprohaptoglobin and haptoglobin in passive heymann nephritis: a differential proteomics approach. J. Proteome Res. 2007, 6, 3313-3320.
99. Thongboonkerd. V., Chutipongtanate, S., Kanlaya, R., Songtawee, N. et al., Proteomic identification of alterations in metabolic enzymes and signaling proteins in hypokalemic nephropathy. Proteomics 2006, 6, 2273-2285.
100. Wu, T., Xie, C., Bhaskarabhatla, M., Yan, M. et al., Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum. 2007, 56, 949-959.
101. Ngai, H. H., Sit, W. H.,.Jiang, P. P., Xu, R. J. et al., Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J. Proteome Res. 2006, 5, 3038-3047.
102. Curthoys, N. P., Taylor, L., Hoffert, J. D., Knepper, M. A., Proteomic analysis of the adaptive response of rat renal proximal tubules to metabolic acidosis. Am. J. Physiol. Renal Physiol. 2007, 292, F140-F147.
103. Lukas, T. J., Luo, W. W., Mao, H., Cole, N. et al., Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis. Mol. Cell. Proteomics 2006, 5, 1233-1244.
104. Perluigi, M., Fai Poon, H., Hensley, K., Pierce, W. M. et al., Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice - a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 38, 960-968.
105. David, D. C., Ittner, L. M., Gehrig, P., Nergenau, D. et al., Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics 2006, 6, 6566-6577.
106. Sizova, D., Charbaut, E., Delalande, F., Poirier, F. et al., Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis. Neurobiol. Aging 2007, 28, 357-370.
107. Wilson, K. E., Marouga, R., Prime, J. E., Pashby, D. P. et al., Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 2005, 5, 3851-3858.
108. Boyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J. et al., Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiol. Aging 2006, 27, 1239-1249.
109. Boyd-Kimball, D., Castegna, A., Sultana, R., Poon, H. F. et al., Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res. 2005, 1044, 206-215.
110. David, D. C., Hauptmann, S., Scherping, I., Schuessel, K. et al., Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J. Biol. Chem. 2005, 280, 23802-23814.
111. Poon, H. F., Farr, S. A., Thongboonkerd, V., Lynn, B. C. et al., Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem. Int. 2005, 46, 159-168.
112. Deshane, J., Chaves, L., Sarikonda, K. V., Isbell, S. et al., Proteomics analysis of rat brain protein modulations by grape seed extract. J. Agric. Food Chem. 2004, 52, 7872-7883.
113. Vercauteren, F. G., Clerens, S., Roy, L., Hamel, N. et al., Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Brain Res. Mol. Brain Res. 2004, 132, 241-259.
114. Shin, S. J., Lee, S. E., Boo, J. H., Kim, M. et al., Profiling proteins related to amyloid deposited brain of Tg2576 mice. Proteomics 2004, 4, 3359-3368.
115. Choi, J., Forster, M. J., McDonald, S. R., Weintraub, S. T. et al., Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic. Biol. Med. 2004, 36, 1155-1162.
116. Bagshaw, R. D., Pasternak, S. H., Mahuran, D. J., Callahan, J. W., Nicastrin is a resident lysosomal membrane protein. Biochem. Biophys. Res. Commun. 2003, 300, 615-618.
117. Tilleman, K., Stevens, I., Spittaels, K., Haute, C. V. et al., Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2002, 2, 94-104.
118. Kromer, S. A., Kessler, M. S., Milfay, D., Birg, I. N. et al., Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J. Neurosci. 2005, 25, 4375-4384.
119. Haskins, W. E., Kobeissy, F. H., Wolper, R. A., Ottens, A. K. et al., Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry. J. Neurotrauma 2005, 22, 629-644.
120. Sheikh, A. M., Barrett, C., Villamizar, N., Alzate, O. et al., Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 2006, 132, 820-828.
121. Mu, J., Xie, P., Yang, Z. S., Yang, D. L. et al., Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model. Neurosci. Lett. 2007, 416, 252-256.
122. Shin, J. H., Yang, J. W., Le Pecheur, M., London, J. et al., Altered expression of hypothetical proteins in hippocampus of transgenic mice overexpressing human Cu/Zn-superoxide dismutase 1. Proteome Sci. 2004, 2, 2.
123. Junker, H., Spate, K., Suofu, Y., Walther, R. et al., Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy. Epilepsia 2005, 46, 339-343.
124. Li, X., Miyajima, M., Mineki, R., Taka, H. et al., Analysis of cerebellum proteomics in the hydrocephalic H-Tx rat. Neuroreport 2005, 16, 571-574.
125. Kunz, S., Tegeder, I., Coste, O., Marian, C. et al., Comparative proteomic analysis of the rat spinal cord in inflammatory and neuropathic pain models. Neurosci. Lett. 2005, 381, 289-293.
126. Wang, X., Zhu, C., Wang, X., Gerwien, J. G. et al., The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J. Neurochem. 2004, 91, 900-910.
127. Prokai, L., Zharikova, A. D., Stevens, S. M., Jr., Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J. Mass Spectrom. 2005, 40, 169-175.
128. Wood-Allum, C. A., Barber, S. C., Kirby, J., Heath, P. et al., Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 2006, 129, 1693-1709.
129. Hu, J., Qian, J., Borisov, O., Pan, S. et al., Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine-specific isobaric tags. Proteomics 2006, 6, 4321-4334.
130. Zabel, C., Sagi, D., Kaindl, A. M., Steireif, N. et al., Comparative proteomics in neurodegenerative and non-neuro-degenerative diseases suggest nodal point proteins in regulatory networking. J. Proteome Res. 2006, 5, 1948-1958.
131. Krapfenbauer, K., Berger, M., Friedlein, A., Lubec, G. et al., Changes in the levels of low-abundance brain proteins induced by kainic acid. Eur. J. Biochem. 2001, 268, 3532-3537.
132. Alzate, O., Hussain, S. R., Goettl, V. M., Tewari, A. K. et al., Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Brain Res. Mol. Brain Res. 2004, 128, 193-200.
133. Sung, H. J., Kim, Y. S., Kim, I. S., Jang, S. W. et al., Proteomic analysis of differential protein expression in neuropathic pain and electroacupuncture treatment models. Proteomics 2004, 4, 2805-2813.
134. Skold, K., Svensson, M., Nilsson, A., Zhang, X. et al., Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J. Proteome Res. 2006, 5, 262-269.
135. Periquet, M., Corti, O., Jacquier, S., Brice, A., Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J. Neurochem. 2005, 95, 1259-1276.
136. De Iuliis, A., Grigoletto, J., Recchia, A., Giusti, P. et al., A proteomic approach in the study of an animal model of Parkinson's disease. Clin. Chim. Acta. 2005, 357, 202-209.
137. Jin, J., Meredith, G. E., Chen, L., Zhou, Y. et al., Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 2005, 134, 119-138.
138. La, Y., Wan, C., Zhu, H., Yang, Y. et al., Hippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/ clozapine treated rats. Neurosci. Lett. 2006, 408, 29-34.
139. Sironi, L., Guerrini, U., Tremoli, E., Miller, I. et al., Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J. Neurosci. Res. 2004, 78, 115-122.
140. Dhodda, V. K., Sailor, K. A., Bowen, K. K., Vemuganti, R., Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J. Neurochem. 2004, 89, 73-89.
141. Fornage, M., Swank, M. W., Boerwinkle, E., Doris, P. A., Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility. Physiol. Genomics 2003, 15, 75-83.
142. Sironi, L., Tremoli, E., Miller, I., Guerrini, U. et al., Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics. Stroke 2001, 32, 753-760.
143. Kochanek, A. R., Kline, A. E., Gao, W. M., Chadha, M. et al., Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact. Dev. Neurosci. 2006, 28, 410-419.
144. Siman, R., McIntosh, T. K., Soltesz, K. M., Chen, Z. et al., Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol. Dis. 2004, 16, 311-320.
145. Ge, Y., Rajkumar, L., Guzman, R. C., Nandi, S. et al., Multiplexed fluorescence detection of phosphorylation, glycosylation, and total protein in the proteomic analysis of breast cancer refractoriness. Proteomics 2004, 4, 3464-3467.
146. Huang, C. M., Ananthaswamy, H. N., Barnes, S., Ma, Y. et al., Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. Proteomics 2006, 6, 6107-6116.
147. Drew, J. E., Rucklidge, G. J., Duncan, G., Lufty, A. et al., A proteomics approach to identify changes in protein profiles in pre-cancerous colon. Biochem. Biophys. Res. Commun. 2005, 330, 81-87.
148. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F. et al., Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA 2005, 102, 779-784.
149. Ward, D. G., Wei, W., Cheng, Y., Billingham, L. J. et al., Plasma proteame analysis reveals the geographical origin and liver tumor status of Dab (Limanda limanda) from UK marine waters. Environ. Sci. Technol. 2006, 40, 4031-4036.
150. Hood, B. L., Lucas, D. A., Kim, G., Chan, K. C. et al., Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model. J. Am. Soc. Mass Spectrom. 2005, 16, 1221-1230.
151. Rantalainen, M., Cloarec, O., Beckonert, O., Wilson, I. D. et al., Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J. Proteome Res. 2006, 5, 2642-2655.
152. Goishi, K., Shimizu, A., Najarro, G., Watanabe, S. et al., AlphaA-crystallin expression prevents gamma-crystallin insolubility and cataract formation in the zebrafish cloche mutant lens. Development 2006, 133, 2585-2593.
153. Liu, S., Zhang, Y., Xie, X., Hu, W. et al., Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat. Cell. Mol. Immunol. 2007, 4, 65-70.
154. Bhattacharya, S. K., Crabb, J. S., Bonilha, V. L., Gu, X. et al., Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci. 2006, 47, 2508-2514.
155. Tezel, G., Yang, X., Cai, J., Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46, 3177-3187.
156. Bertrand, E., Fritsch, C., Diether, S., Lambrou, G. et al. Identification of apolipoprotein A-I as a "STOP" signal for myopia. Mol. Cell. Proteomics 2006, 5, 2158-2166.
157. Umeda, S., Suzuki, M. T., Okamoto, H., Ono, F. et al., Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 2005, 19, 1683-1685.
158. Lorenz, P., Bantscheff, M., Ibrahim, S, M., Thiesen, H. J. et al., Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis. Clin. Chem. Lab. Med. 2003, 41, 1622-1632.
159. de Roos, B., Duivenvoorden, I., Rucklidge, G., Reid, M. et al., Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data. FASEB J. 2005, 19, 813-815.
160. Crouser, E. D., Julian, M. W., Huff, J. E., Mandich, D. V. et al., A proteomic analysis of liver mitochondria during acute endotoxemia. Intensive Care Med. 2006, 32, 1252-1262.
161. Oh, T. Y., Yeo, M., Han, S. U., Cho, Y. K. et al., Synergism of Helicobacter pylori infection and stress on the augmentation of gastric mucosal damage and its prevention with alpha-tocopherol. Free Radic. Biol. Med. 2005, 38, 1447-1457.
162. Fan, X., Zhang, H., Zhang, S., Bagshaw, R. D. et al., Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C). Am. J. Hum. Genet. 2006, 79, 738-744.
163. Thongboonkerd, V., Kanlaya, R., Sinchaikul, S., Parichatikanond, P. et al., Proteomic identification of altered proteins in skeletal muscle during chronic potassium depletion: Implications for hypokalemic myopathy. J. Proteome Res. 2006, 5, 3326-3335.
164. Gineste, C., Ho, L., Pompl, P., Bianchi, M. et al., High-throughput proteomics and protein biomarker discovery in an
165. Walgren, J. L., Mitchell, M. D., Whiteley, L. O., Thompson, D. C., Identification of novel peptide safety markers for exocrine pancreatic toxicity induced by cyanohydroxybutene. Toxicol. Sci. 2007, 96, 174-183.
166. Fehniger, T. E., Sato-Folatre, J. G., Malmstrom, J., Berglund, M. et al., Exploring the context of the lung proteome within the airway mucosa following allergen challenge. J. Proteome Res. 2004, 3, 307-320.
167. Jeong, H., Rhim, T., Ahn, M. H., Yoon, P. O. et al., Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J. Korean Med. Sci. 2005, 20, 579-585.
168. Zhao, J., Zhu, H., Wong, C. H., Leung, K. Y. et al., Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 2005, 5, 2799-2807.
169. Roh, G. S., Shin, Y., Seo, S. W., Yoon, B. R. et al., Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 2004, 4, 3318-3327.
170. Houtman, R., Krijgsveld, J., Kool, M., Romijn, E. P. et al., Lung proteome alterations in a mouse model for non-allergic asthma. Proteomics 2003, 3, 2008-2018.
171. Gabr, A. A., Reed, M., Newman, D. R., Pohl, J. et al., Alterations in cytoskeletal and immune function-related proteome profiles in whole rat lung following intratracheal instillation of heparin. Respir. Res. 2007, 8, 36.
172. Lantz, R. C., Lynch, B. J., Boitano, S., Poplin, G. S. et al., Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Environ. Health Perspect. 2007, 115, 586-591.
173. Yang, Y. H., Xi, Z. G., Chao, F. H., Yang, D. F., Effects of formaldehyde inhalation on lung of rats. Biomed. Environ. Sci. 2005, 18, 164-168.
174. Bozinovski, S., Cross, M., Vlahos, R., Jones, J. E. et al., S100AB chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo. J. Proteome Res. 2005, 4, 136-145.